Guobang Pharmaceutical Overview
- Year Founded
-
1996
- Status
-
Public
- Employees
-
4,251
- Stock Symbol
-
605507
- Investments
-
1
- Share Price
-
$2.31
- (As of Friday Closing)
Guobang Pharmaceutical General Information
Description
Guobang Pharma Ltd is engaged in the Research, development, production and sales of products related to the pharmaceutical and animal health products fields.
Contact Information
Website
www.gbgcn.comCorporate Office
- No. 60, Xingmei Avenue
- Xinchang Provincial High-tech Industrial Park
- Shaoxing, Zhejiang
- China
Corporate Office
- No. 60, Xingmei Avenue
- Xinchang Provincial High-tech Industrial Park
- Shaoxing, Zhejiang
- China
Guobang Pharmaceutical Stock Performance
As of 13-Nov-2026, Guobang Pharmaceutical’s stock price is $2.31. Its current market cap is $1.81B with 782M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.31 | $2.32 | $2.11 - $3.12 | $1.81B | 782M | 6.85M | $0.12 |
Guobang Pharmaceutical Financials Summary
As of 30-Sep-2026, Guobang Pharmaceutical has a trailing 12-month revenue of $889M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 1,888,776 | 1,802,580 | 1,423,836 | 1,168,391 |
| Revenue | 889,398 | 835,924 | 820,970 | 756,119 |
| EBITDA | 104,763 | 199,578 | 183,778 | 139,873 |
| Net Income | 90,232 | 114,140 | 108,926 | 86,569 |
| Total Assets | 1,680,020 | 1,569,974 | 1,476,752 | 1,461,732 |
| Total Debt | 142,150 | 141,696 | 106,029 | 135,890 |
Guobang Pharmaceutical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Guobang Pharmaceutical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Guobang Pharmaceutical Investments (1)
Guobang Pharmaceutical’s most recent deal was a PE Growth/Expansion with Hangzhou Shenshi Energy Conservation Technology for . The deal was made on 17-Nov-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Hangzhou Shenshi Energy Conservation Technology | 17-Nov-2023 | PE Growth/Expansion | Holding Companies |
Guobang Pharmaceutical ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
37.64 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 354
Rank
Percentile
Guobang Pharmaceutical FAQs
-
When was Guobang Pharmaceutical founded?
Guobang Pharmaceutical was founded in 1996.
-
Where is Guobang Pharmaceutical headquartered?
Guobang Pharmaceutical is headquartered in Shaoxing, China.
-
What is the size of Guobang Pharmaceutical?
Guobang Pharmaceutical has 4,251 total employees.
-
What industry is Guobang Pharmaceutical in?
Guobang Pharmaceutical’s primary industry is Pharmaceuticals.
-
Is Guobang Pharmaceutical a private or public company?
Guobang Pharmaceutical is a Public company.
-
What is Guobang Pharmaceutical’s stock symbol?
The ticker symbol for Guobang Pharmaceutical is 605507.
-
What is the current stock price of Guobang Pharmaceutical?
As of 13-Nov-2026 the stock price of Guobang Pharmaceutical is $2.31.
-
What is the current market cap of Guobang Pharmaceutical?
The current market capitalization of Guobang Pharmaceutical is $1.81B.
-
What is Guobang Pharmaceutical’s current revenue?
The trailing twelve month revenue for Guobang Pharmaceutical is $889M.
-
What is Guobang Pharmaceutical’s annual earnings per share (EPS)?
Guobang Pharmaceutical’s EPS for 12 months was $0.12.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
